Complications of mitomycin C therapy in 100 eyes with ocular surface neoplasia

British Journal of Ophthalmology

Volumn 90, Issue 7, 2006, Pages 819-822

  Khong, J J ^a   Muecke, James ^a  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

LUBRICATING AGENT; MITOMYCIN C;

ALLERGIC REACTION; ARTICLE; COMPRESSION THERAPY; CONJUNCTIVA TUMOR; CONTROLLED STUDY; CORNEA TUMOR; EPIPHORA; EYE TUMOR; FEMALE; FIBROXANTHOMA; FOLLOW UP; HUMAN; LACRIMATION DISORDER; MAJOR CLINICAL STUDY; MALE; MELANOMA; MELANOSIS; PRIORITY JOURNAL; PTOSIS; RETROSPECTIVE STUDY; SEBACEOUS CARCINOMA; SQUAMOUS CELL CARCINOMA; STENOSIS; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADENOCARCINOMA, SEBACEOUS; ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; CONJUNCTIVAL NEOPLASMS; CORNEAL DISEASES; DRUG HYPERSENSITIVITY; EYE NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HISTIOCYTOMA, BENIGN FIBROUS; HUMANS; LACRIMAL APPARATUS DISEASES; LACRIMAL DUCT OBSTRUCTION; MALE; MELANOMA; MELANOSIS; MITOMYCIN; RETROSPECTIVE STUDIES;

EID: 33745644013     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2005.086850     Document Type: Article

References (23)

1. Frucht-Pery J, Sugar J, Baum J, et al. Mitomycin C treatment for conjunctival-corneal intraepithelial neoplasia. A multicenter experience. Ophthalmology 1997;104:2085-93.
2. Daniell M, Maini R, Tole D. Use of mitomycin C in the treatment of corneal conjunctival intraepithelial neoplaisa. Clin Experiment Ophthalmol 2002;30:94-8.
3. Heigle TJ, Stulting RD, Palay DA. Treatment of recurrent conjunctival epithelial neoplasia with topical mitomycin C. Am J Ophthalmol 1997;124:397-9.
4. Wilson MW, Hungerford JL, George SM, et al. Topical mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia. Am J Ophthalmol 1997;124:303-11.
5. Frucht-Pery J, Pe'er J. Use of mitomycin C in the treatment of conjunctival primary acquired melanosis with atypia. Arch Ophthalmol 1996;113:1261-4.
6. Finger PT, Grazyna C, Liarikos S. Topical mitomycin C chemotherapy for conjunctival melanoma and PAM with atypia. Br J Ophthalmol 1998;82:476-9.
7. Demirci H, McCormick S, Finger P. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired metanosis with atypia: clinical experience with histopathologic observations. Arch Ophthalmol 2000;118:885-91.
8. Shields CL, Naseripour M, Shields JA. Topical mitomycin-C for pagetoid invasion of the conjunctiva by eyelid sebaceous gland carcinoma. Ophthalmology 2002;109:2129-33.
9. Frucht-Pery J, Rozenman Y. Mitomycin C therapy for corneal intraepithelial neoplasia. Am J Ophthalmol 1994;117:164-8.
10. Shields CL, Naseripour M, Shields JA. Topical mitomycin C for extensive, recurrent conjunctival-corneal squamous cell carcinoma. Am J Ophthalmol 2002;133:601-6.
11. Dudney BW, Malecha MA. Limbal stem cell deficiency following topical mitomycin C treatment of conjunctival-corneal intraepithelial neoplasia. Am J Ophthalmol 2004;137:950-1.
12. Sacu S, Ségur-Eltz N, Horvat R, et al. Intumescent cataract after topical mitomycin C for conjunctival malignant melanoma. Am J Ophthalmol 2003;136:375-7.
13. Billing K, Karagiannis A, Selva D. Punctal-canalicular stenosis associated with mitomycin-C for corneal epithelial dysplasia. Am J Ophthalmol 2003;136:746-7.
14. Kopp ED, Seregard S. Epiphora as a side effect of topical mitomycin C. Br J Ophthalmol 2004;88:1422-24.
15. Kunkeler L, Nieboer C, Bruynzeel DP. Type III and type IV hypersensitivity reactions due to mitomycin C. Contact Dermatitis 2000;42:74-6.
16. Colver GB, Inglis JA, McVittie E, et al. Dermatitis due to intravesical mitomycin C: a delayed-type hypersensitivity reaction? Br J Dermatol 1990;122:217-24.
17. Torrijos EG, Borja J, Galindo PA, et al. Allergic contact dermatitis from mitomycin C. Allergy 1997;52:687.
18. Ma'luf RN, Hamush NG, Awwad ST, et al. Mitomycin C as adjunct therapy in correcting punctal stenosis. Ophthal Plast Reconstr Surg 2002;18:285-8.
19. Esmaeli B, Valera V, Ahmadi MA, et al. Canalicular stenosis secondary to docetaxel (taxotere): a newly recognized side effect. Ophthalmology 2001;108:994-5.
20. Eiseman AS, Flanagan JC, Brooks AB, et al. Ocular surface, ocular adnexal, and lacrimal complications associated with the use of systemic 5-fluorouracil. Ophthal Plast Reconstr Surg 2003;19:216-24.
21. Esmaeli B, Golio D, Lubecki L, et al. Canalicular and nasolacrimal duct blockage: an ocular side effect associated with the antineoplastic drug S-1. Am J Ophthalmol 2005;140:325-7.
22. Dougherty PJ, Hardten DR, Lindstrom RL. Corneoscleral melt after pterygium surgery using a single intraoperative application of mitomycin-C. Cornea 1996;15:537-40.
23. Rubinfeld RS, Pfister RR, Stein RM, et al. Serious complications of topical mitomycin-C after pterygium surgery. Ophthalmology 1992;99:1647-54.